SDZ-PSD-958 is a selective dopamine D1 and D5 receptor antagonist which was under development for the treatment of psychotic disorders but was never marketed. Its route of administration is unknown.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.